Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating... see more

CSE:BRAX - Post Discussion

Braxia Scientific Corp > A ventriloquist, a dummy, and a tin foil hat.
View:
Post by cautiousguy on May 26, 2022 8:31pm

A ventriloquist, a dummy, and a tin foil hat.

Newcon...you outdid yourself with your latest rant.  You got confused at one point and forgot to switch back to the newcon persona after writing as korncon.  But that just added to the madness.
Comment by newcoin on May 27, 2022 12:32am
You are constantly confused. Tell us about your boss - H.C. Wainwright & Co. if you've got the balls. Oh, wait ... I forgot.
Comment by cautiousguy on May 27, 2022 1:48am
Forgot what?  How stupid, sophmoric, and uninformed you are?  I'll remind you.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities